VirginiaAccess to investigational drugs, etc.; patient with severely debilitating condition.
What it does
Access to investigational drugs, biological products, and devices; patient with severely debilitating condition. Allows a patient who has a severely debilitating condition, defined in the bill as a disease or condition that causes major irreversible morbidity, to access investigational drugs, biological products, and devices when certain criteria are met. Under current law, only a patient who has a terminal condition may access such drugs, products, and devices.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Feb 18Left in Committee Health and Human ServicesLatest
- Feb 10Subcommittee recommends laying on the table (7-Y 1-N)
- Vote recorded Subcommittee recommends laying on the table. Result: pass.Lower
- Feb 5Fiscal Impact Statement from Department of Planning and Budget (HB1025)
- Jan 23Assigned sub: HealthMinor
- Jan 14Referred to Committee on Health and Human ServicesMinor
- Jan 14Prefiled and ordered printed; Offered 01-14-2026 26102452DIntroduced